-transparent.png){kind=logo}
Whole genome sequence of the rifamycin B-producing strain Amycolatopsis mediterranei S699. 2011
Mansi Verma, and
Jaspreet Kaur, and
Mukesh Kumar, and
Kirti Kumari, and
Anjali Saxena, and
Shailly Anand, and
Aeshna Nigam, and
Vydianathan Ravi, and
Saurabh Raghuvanshi, and
Paramjit Khurana, and
Akhilesh K Tyagi, and
Jitendra P Khurana, and
Rup Lal
Department of Zoology, University of Delhi, Delhi 110 007, India.
Amycolatopsis mediterranei S699 is an actinomycete that produces an important antibiotic, rifamycin B. Semisynthetic derivatives of rifamycin B are used for the treatment of tuberculosis, leprosy, and AIDS-related mycobacterial infections. Here, we report the complete genome sequence (10.2 Mb) of A. mediterranei S699, with 9,575 predicted coding sequences.
Related Publications
Mansi Verma, and
Jaspreet Kaur, and
Mukesh Kumar, and
Kirti Kumari, and
Anjali Saxena, and
Shailly Anand, and
Aeshna Nigam, and
Vydianathan Ravi, and
Saurabh Raghuvanshi, and
Paramjit Khurana, and
Akhilesh K Tyagi, and
Jitendra P Khurana, and
Rup Lal
September 2020,
Biomolecules,
Mansi Verma, and
Jaspreet Kaur, and
Mukesh Kumar, and
Kirti Kumari, and
Anjali Saxena, and
Shailly Anand, and
Aeshna Nigam, and
Vydianathan Ravi, and
Saurabh Raghuvanshi, and
Paramjit Khurana, and
Akhilesh K Tyagi, and
Jitendra P Khurana, and
Rup Lal
June 2021,
Biomolecules,
Mansi Verma, and
Jaspreet Kaur, and
Mukesh Kumar, and
Kirti Kumari, and
Anjali Saxena, and
Shailly Anand, and
Aeshna Nigam, and
Vydianathan Ravi, and
Saurabh Raghuvanshi, and
Paramjit Khurana, and
Akhilesh K Tyagi, and
Jitendra P Khurana, and
Rup Lal
August 2014,
Genome announcements,
Mansi Verma, and
Jaspreet Kaur, and
Mukesh Kumar, and
Kirti Kumari, and
Anjali Saxena, and
Shailly Anand, and
Aeshna Nigam, and
Vydianathan Ravi, and
Saurabh Raghuvanshi, and
Paramjit Khurana, and
Akhilesh K Tyagi, and
Jitendra P Khurana, and
Rup Lal
December 2002,
The Journal of general and applied microbiology,
Mansi Verma, and
Jaspreet Kaur, and
Mukesh Kumar, and
Kirti Kumari, and
Anjali Saxena, and
Shailly Anand, and
Aeshna Nigam, and
Vydianathan Ravi, and
Saurabh Raghuvanshi, and
Paramjit Khurana, and
Akhilesh K Tyagi, and
Jitendra P Khurana, and
Rup Lal
May 2000,
The Journal of antibiotics,
Mansi Verma, and
Jaspreet Kaur, and
Mukesh Kumar, and
Kirti Kumari, and
Anjali Saxena, and
Shailly Anand, and
Aeshna Nigam, and
Vydianathan Ravi, and
Saurabh Raghuvanshi, and
Paramjit Khurana, and
Akhilesh K Tyagi, and
Jitendra P Khurana, and
Rup Lal
August 2005,
Microbiology (Reading, England),
Mansi Verma, and
Jaspreet Kaur, and
Mukesh Kumar, and
Kirti Kumari, and
Anjali Saxena, and
Shailly Anand, and
Aeshna Nigam, and
Vydianathan Ravi, and
Saurabh Raghuvanshi, and
Paramjit Khurana, and
Akhilesh K Tyagi, and
Jitendra P Khurana, and
Rup Lal
September 2020,
Indian journal of microbiology,
Mansi Verma, and
Jaspreet Kaur, and
Mukesh Kumar, and
Kirti Kumari, and
Anjali Saxena, and
Shailly Anand, and
Aeshna Nigam, and
Vydianathan Ravi, and
Saurabh Raghuvanshi, and
Paramjit Khurana, and
Akhilesh K Tyagi, and
Jitendra P Khurana, and
Rup Lal
October 2003,
Biotechnology letters,
Mansi Verma, and
Jaspreet Kaur, and
Mukesh Kumar, and
Kirti Kumari, and
Anjali Saxena, and
Shailly Anand, and
Aeshna Nigam, and
Vydianathan Ravi, and
Saurabh Raghuvanshi, and
Paramjit Khurana, and
Akhilesh K Tyagi, and
Jitendra P Khurana, and
Rup Lal
October 2010,
Cell research,
Mansi Verma, and
Jaspreet Kaur, and
Mukesh Kumar, and
Kirti Kumari, and
Anjali Saxena, and
Shailly Anand, and
Aeshna Nigam, and
Vydianathan Ravi, and
Saurabh Raghuvanshi, and
Paramjit Khurana, and
Akhilesh K Tyagi, and
Jitendra P Khurana, and
Rup Lal
October 2012,
Journal of bacteriology,
